The introduction of nicotinamide to be a nicotine substitution in e-cigarette and smokeless products and solutions represents a major regulatory obstacle for your FDA. Nicotinamide doesn't have nicotinic receptor agonist activity and is known to work as a sedative at high dosages6. The promises created by Nicotine River, ECBlend, along with other v